Lyphomed
Executive Summary
Granted preliminary injunction restraining Professional Compounding Centers of America, Inc. "from acting directly or indirectly" to sell pentamidine or contract doctors, hospitals, or pharmacists to solicit orders for the drug. In a May 23 motion filed in Houston federal court, Lyphomed accused Professional Compounding Centers of "selling bulk pentamidine, without FDA approval, to pharmacies." A trial date will be scheduled "shortly after Sept. 1, 1989," the injunction states.